Literature DB >> 12198691

Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease.

Göte Forsberg1, Olle Hernell, Silvia Melgar, Anne Israelsson, Sten Hammarström, Marie-Louise Hammarström.   

Abstract

BACKGROUND & AIMS: Specific T-lymphocyte reactions are central in the pathogenesis of celiac disease, an inflammatory small-bowel enteropathy caused by a permanent intolerance to gluten. To delineate local T-lymphocyte responses to gluten, the cytokine expression in jejunal T lymphocytes of pediatric celiac patients with active disease, i.e., untreated and gluten-challenged celiac patients, was determined and compared with that of treated, symptom-free celiac patients and controls.
METHODS: Biopsy samples were collected from celiac patients and controls. Intraepithelial and lamina propria T lymphocytes were isolated separately, and the cytokine messenger RNA levels were determined by using quantitative real-time reverse-transcription polymerase chain reaction. Interferon (IFN)-gamma and interleukin (IL)-10 were determined at the protein level by immunohistochemistry.
RESULTS: Active celiac disease was characterized by distortions in cytokine expression by T lymphocytes, with highly significant increases of IFN-gamma and IL-10 but no concomitant increases in tumor necrosis factor alpha, transforming growth factor beta1, or IL-2 and no induction of IL-4. A marked shift of IFN-gamma and IL-10 production from the lamina propria to the epithelium was characteristic of active celiac disease, and as many as one fourth of the intraepithelial lymphocytes expressed IFN-gamma. Intraepithelial T lymphocytes in treated, symptom-free celiac patients still had increased IFN-gamma levels compared with controls.
CONCLUSIONS: In celiac patients, gluten intake seems to cause an overreaction in intraepithelial T lymphocytes, with uncontrolled production of IFN-gamma and IL-10. This may cause both recruitment of intraepithelial lymphocytes and a leaky epithelium, leading to a vicious circle with amplified immune activity and establishment of intestinal lesions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12198691     DOI: 10.1053/gast.2002.35355

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  48 in total

1.  Analysis of the expression of MICA in small intestinal mucosa of patients with celiac disease.

Authors:  Ainhoa Martín-Pagola; Lourdes Ortiz; Gustavo Pérez de Nanclares; Juan Carlos Vitoria; Luis Castaño; J Ramón Bilbao
Journal:  J Clin Immunol       Date:  2003-11       Impact factor: 8.317

2.  Interleukin-10 haplotypes in Celiac Disease in the Spanish population.

Authors:  Concepción Núñez; Diana Alecsandru; Jezabel Varadé; Isabel Polanco; Carlos Maluenda; Miguel Fernández-Arquero; Emilio G de la Concha; Elena Urcelay; Alfonso Martínez
Journal:  BMC Med Genet       Date:  2006-03-31       Impact factor: 2.103

3.  Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease.

Authors:  Francisco León; Laura Sánchez; Cristina Camarero; Garbiñe Roy
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-gamma and IL-10, the latter promoting Fas ligand-mediated cytotoxicity.

Authors:  Ellen C Ebert
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

5.  Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.

Authors:  S Melgar; M M-W Yeung; A Bas; G Forsberg; O Suhr; A Oberg; S Hammarstrom; A Danielsson; M-L Hammarstrom
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

6.  Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

Authors:  A Di Sabatino; R Ciccocioppo; F Cupelli; B Cinque; D Millimaggi; M M Clarkson; M Paulli; M G Cifone; G R Corazza
Journal:  Gut       Date:  2005-08-16       Impact factor: 23.059

7.  Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients.

Authors:  D Bernardo; J A Garrote; Y Allegretti; A León; E Gómez; J F Bermejo-Martin; C Calvo; S Riestra; L Fernández-Salazar; A Blanco-Quirós; F Chirdo; E Arranz
Journal:  Clin Exp Immunol       Date:  2008-10       Impact factor: 4.330

8.  Bifidobacterium strains suppress in vitro the pro-inflammatory milieu triggered by the large intestinal microbiota of coeliac patients.

Authors:  Marcela Medina; Giada De Palma; Carmen Ribes-Koninckx; Miguel Calabuig; Yolanda Sanz
Journal:  J Inflamm (Lond)       Date:  2008-11-03       Impact factor: 4.981

9.  Aberrant extrathymic T cell receptor gene rearrangement in the small intestinal mucosa: a risk factor for coeliac disease?

Authors:  A Bas; G Forsberg; V Sjöberg; S Hammarström; O Hernell; M-L Hammarström
Journal:  Gut       Date:  2008-02-25       Impact factor: 23.059

10.  Vibrio cholerae cytolysin causes an inflammatory response in human intestinal epithelial cells that is modulated by the PrtV protease.

Authors:  Gangwei Ou; Pramod Kumar Rompikuntal; Aziz Bitar; Barbro Lindmark; Karolis Vaitkevicius; Sun Nyunt Wai; Marie-Louise Hammarström
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.